BBC 股价预测及 ETF 分析 - 分红·管理费·持仓·NAV·RSI·MACD

Q: BBC是否支付分红（分配）？

BBC的分红收益率约为 1.46%。

BBC

Virtus Biotech Clinical Trials ETF

收盘价 11月10日 4:00 PM ET（韩国 11/11 06:00）

$44.88

-0.11 ▼ -0.25%

11月10日 4:00 PM ET（韩国 11/11 06:00）

$44.88

+0.00 +0.00%

下降三角形阻力线 43.29 支撑线 39.07 突破阻力连续7天同一条线

AI 绘制的图表形态仅供参考。

详细指标表

Category ⓘ	US Equities - Industry Sector	Expense ⓘ	0.65%	Return% 1Y ⓘ	52.36%	Total Holdings ⓘ	130	Perf Week ⓘ	4.84%	Volume ⓘ	54,143
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$32M	Return% 3Y ⓘ	36.17%	NAV ⓘ	$45.10	Perf Month ⓘ	4.23%	Avg Volume ⓘ	0.03M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	$0.66 (1.46%)	Return% 5Y ⓘ	0.2%	52W High ⓘ	-20.11%	Perf Quarter ⓘ	-15.41%	Rel Volume ⓘ	1.79
Active/Passive ⓘ	Passive	Div Gr. 3/5Y ⓘ	-	Return% 10Y ⓘ	9.83%	52W Low ⓘ	47.29%	Perf Half Y ⓘ	0.76%	Prev Close ⓘ	$44.99
IPO ⓘ	2014/12/17	Flows% 1M ⓘ	-24.91%	Return% SI ⓘ	4.89%	RSI (14) ⓘ	54.47	Perf YTD ⓘ	16.39%	Price ⓘ	$44.88
Beta ⓘ	0.94	Flows% 3M ⓘ	-24.91%	Flows% YTD ⓘ	-15.61%	Flows% 1Y ⓘ	5.84%	Perf Year ⓘ	45.53%	Volatility(W/M) ⓘ	4.93% 3.71%
SMA20 ⓘ	6.06%	SMA50 ⓘ	-1.35%	SMA200 ⓘ	-1.76%	ATR ⓘ	1.7

ETF 简介

Virtus Biotech Clinical Trials ETFBBC | NYSE | 医疗板块查看深度分析

Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

BBC ETF 一览

0.65% 越低越好

$32M 管理资产

130只

1.46%

上市日期 2014年

运作方式跟踪指数

管理公司 Virtus

主要持仓持有130只

前10大持仓占 基金的14%

均匀分散在众多持仓中。